CAG, BAC unite to enhance pharma capabilities

Singapore’s Changi Airport Group (CAG) has strengthened its alliance with Brussels Airport Company (BAC) in Belgium to improve gloabl air cargo operations. The firms reached a memorandum of understanding (MoU) in this regard, with plans to improve pharmaceutical logistics capabilities and share their best practices. They also intend to perform studies and trials related to digitalisation and sustainability. CAG Air Hub and Cargo Development executive vice-president Lim Ching Kiat said: “The industry has witnessed how the Covid-19 pandemic has transformed the air cargo supply chain. More than ever, handling capabilities are key to the competitiveness of the air cargo ecosystem.
“As CAG pushes forward with our digitalisation efforts to enhance Changi Airport’s air cargo processes for higher handling efficiency, we look forward to exchanging insights and learning from Brussels Airport and Air Cargo Belgium.” In addition, the companies will focus on a Green Air Pharma Corridor study, which will be conducted in collaboration with other Pharma.Aero members. A non-profit organisation, Pharma.Aero was one of the initial joint initiatives of BAC and CAG, who have partnered on several projects since 2016. Pharma.Aero members share best practices to boost the industry’s pharmaceutical handling capabilities. Additionally, CAG and BAC will work alongside to improve passenger and cargo connectivity between Singapore and Brussels. BAC chief cargo and real estate officer Geert Aerts said: “We are happy to sign this memorandum of understanding with Changi Airport and to further enhance our longstanding partnership. “By exchanging expertise and building on our alliance to tackle the challenges and opportunities of today together, we can leverage the best practices and become more interconnected between our hubs.”